The BioIntelliSense Data-as-a-Service (DaaS) platform and FDA-cleared BioSticker™ on-body sensor are bringing medical grade monitoring and management to the home for scalable remote care.
More News
AccurKardia receives patent for AI-ECG cardiac amyloidosis detection
